Stay updated on Pembrolizumab in Lymphoma Subtypes Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Subtypes Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T15:50:30.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:44:40.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label updates from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T16:40:22.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T16:13:30.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, blocking access to the study record. The content is replaced by an access-denied screen, and the study details and attachments are not visible on this page.
    Difference
    21%
    Check dated 2026-09-20T20:03:43.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing Revision: v3.6.5. This indicates an updated version of the page in the site's content management system.
    Difference
    0.1%
    Check dated 2026-08-30T22:37:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Subtypes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.